Schedule H, H1 and X Drugs Explained (With Examples)

This explains Schedule H, H1 and X drugs tier by tier, including the specific Schedule H1 register your pharmacy must keep, with named examples and the exact record-keeping obligation attached to each.

What is a Schedule H drug?

Schedule H covers standard prescription-only medicines: common blood pressure medications, regular diabetes treatments, and standard anti-infectives that cannot legally be sold without a doctor's prescription. The label requirement is specific: the symbol Rx must appear, with a warning that the drug may be sold by retail only on prescription of a registered medical practitioner.

Beyond the prescription requirement itself, Schedule H imposes no separate register or retention obligation on the pharmacy.

A valid prescription at the point of sale, correctly labelled stock, is the full compliance burden for this tier, which is why it covers the largest volume of medicines a typical pharmacy dispenses day to day, from routine chronic-condition refills to short antibiotic courses.

What is a Schedule H1 drug, and why was it introduced?

Schedule H1 is a stricter sub-category introduced in 2013 specifically to curb misuse of powerful antibiotics, anti-tuberculosis medications, and certain sedatives whose overuse drives antimicrobial resistance. Named examples include Levofloxacin, Moxifloxacin, Tramadol and Zolpidem, spanning both antibiotics and habit-forming sedatives rather than a single drug class.

The label requirement steps up from Schedule H's warning to a red-boxed Rx symbol specifically stating the preparation is dangerous to take except in accordance with medical advice, a visually distinct warning meant to be harder to miss than the standard Schedule H label. The real compliance difference, though, is the register: pharmacies dispensing Schedule H1 drugs must maintain a separate register recording the patient's name and address, the prescribing doctor's details, and the quantity of drug supplied, retained for three years from the date of sale.

What is a Schedule X drug, and what does selling one require?

Schedule X is the strictest tier, covering high-risk narcotics and psychotropic substances with genuine potential for abuse and addiction: morphine, amphetamines, and strong barbiturates are named examples. Selling Schedule X drugs requires a specific government licence beyond the standard retail drug licence, not automatically included when you obtain Form 20 or 21.

This is easy to overlook precisely because the retail licence application doesn't flag it as a separate step.

Record-keeping steps up again from Schedule H1's single register to duplicate prescriptions, where a copy is retained by the pharmacy itself for two years rather than merely logged in a register. Storage requirements step up too, to secure lock-and-key conditions specifically, well beyond the general storage adequate for Schedule H and H1 stock.

How do the three schedules compare directly?

Read the table for the core differences in labelling, records and storage across all three, then the sections that follow for what each obligation actually means day to day at the counter.

Why does H1 specifically target antibiotics and sedatives?

The 2013 introduction of Schedule H1 was a direct regulatory response to rising antimicrobial resistance, driven substantially by unsupervised, repeated antibiotic use that built resistance faster than new antibiotics could be developed to replace what stopped working.

Targeting third and fourth-generation antibiotics specifically, rather than antibiotics broadly, reflects a deliberate choice to protect the newest, most powerful drugs from the overuse pattern that had already compromised older ones. That choice matters clinically: these are often the last effective options when older antibiotics have already failed.

The inclusion of sedatives like Zolpidem alongside antibiotics in the same schedule reflects a different but related concern. Dependency risk serious enough to warrant the same tracking discipline as resistance-driving antibiotics, even though the underlying harm mechanism is completely different.

What happens if a pharmacy doesn't maintain the required register?

Failing to maintain the Schedule H1 register, or failing to retain it for the full three-year period, is a compliance failure independent of whether the underlying sale itself was otherwise legitimate. An inspector reviewing pharmacy records checks the register's existence and completeness specifically, not just whether the drugs on the shelf match what a prescription would allow.

This is exactly the kind of gap that's invisible day to day and only surfaces during an inspection or audit, by which point months or years of incomplete records can't be reconstructed retroactively. Building the register into your dispensing software from the start, so it populates automatically at the point of sale rather than depending on a staff member remembering to log it separately, is what actually closes this gap rather than merely intending to.

How does this affect a hospital pharmacy specifically?

A hospital pharmacy dispensing Schedule H1 antibiotics or sedatives to inpatients and outpatients carries the same register obligation as any retail pharmacy. The higher volume it typically handles makes manual register-keeping considerably more error-prone than at a small standalone chemist, since there are simply more transactions where a step can be skipped under pressure.

Schedule X drugs specifically, if a hospital stocks morphine or similar controlled substances for pain management, require the separate government licence and locked storage regardless of the facility's overall size or reputation.

Our documents checklist and drug licence guide cover the base retail licensing a hospital pharmacy needs. The Schedule X licence is a distinct, additional requirement layered on top when applicable, not something the base retail licence covers automatically.

How should a pharmacy actually implement Schedule H1 register-keeping?

The register itself needs to capture patient name and address, the prescribing doctor's name and registration details, and the exact quantity supplied, all recorded at the moment of sale rather than reconstructed afterward from memory.

Paper registers work but are genuinely fragile over a three-year retention window: pages go missing, ink fades, and a physical book stored in a busy pharmacy is one spill or one misplaced binder away from an incomplete record an inspector will flag.

Digital register-keeping, built into the same point-of-sale system that already handles billing, solves this more durably. It also makes the three-year retention requirement trivial to satisfy, since digital records don't degrade the way paper does, and a backup copy stored off-site protects against the physical loss that paper registers remain vulnerable to for the entire retention period.

Sources

1. 1Schedule H1 Regulation — National TB Elimination Programme, Ministry of Health and Family Welfare
2. 2Central Drugs Standard Control Organisation — Drugs and Cosmetics Act, 1940 and Rules, 1945
3. 3Narcotic Drugs and Psychotropic Substances Act, 1985 — India Code, Ministry of Law and Justice
4. 4Pharmacy Council of India — registration requirements under the Pharmacy Act, 1948
5. 5National TB Elimination Programme — Ministry of Health and Family Welfare, Government of India

This article is for informational purposes and is not a substitute for professional legal or medical advice. Schedule classifications and record-keeping requirements can change; verify current rules with your state Drug Control department before dispensing any scheduled drug.